Merck KGaA (Merck KGaA) Gross-Profit-to-Asset % : 23.82% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Merck KGaA's annualized Gross Profit for the quarter that ended in Dec. 2023 was $12,641 Mil. Merck KGaA's average Total Assets over the quarter that ended in Dec. 2023 was $53,073 Mil. Therefore, Merck KGaA's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 23.82%.

Merck KGaA Gross-Profit-to-Asset % Historical Data

The historical data trend for Merck KGaA's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Gross-Profit-to-Asset % Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

24.87

26.16

27.30

28.28

25.92

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															28.09	27.48	26.13	24.23	23.82

Competitive Comparison of Merck KGaA's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Gross-Profit-to-Asset % falls into.

Merck KGaA Gross-Profit-to-Asset % Calculation

Merck KGaA's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	13514.722	/	( (51414.195	+	52884.406)	/ 2 )
	=	13514.722	/	52149.3005
	=	25.92 %

Merck KGaA's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	12641.22	/	( (53261.473	+	52884.406)	/ 2 )
	=	12641.22	/	53072.9395
	=	23.82 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Merck KGaA Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.